Reports for EFAVIRENZ
Ingredient
EFAVIRENZ
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 600MG 200MG 300MG | TABLET | Avoided shortage | 2020-04-29 | 2020-07-09 | 113424 |
| MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 300MG 200MG 600MG | TABLET | Actual shortage | 2025-04-14 | 2025-04-14 | 255042 |
| MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 600MG 300MG 200MG | TABLET | Resolved | 2018-04-27 | 2019-06-19 | 47356 |
| PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 600MG 300MG 200MG | TABLET | Resolved | 2022-08-15 | 2022-10-24 | 166805 |
| SUSTIVA 50MG | 50MG | CAPSULE | Resolved | 2020-10-05 | 2020-12-11 | 125709 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2025-01-09 | 2025-04-29 | 247357 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195858 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2023-04-27 | 2023-07-06 | 190767 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2020-05-01 | 2020-06-11 | 113782 |
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Actual shortage | 2025-01-23 | 2025-01-23 | 248436 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATRIPLA | 300MG 200MG 600MG | TABLET | Discontinued | 2021-08-17 | 2022-01-01 | 144260 |
| SUSTIVA 200MG | 200MG | CAPSULE | Discontinued | 2021-06-14 | 2023-04-01 | 140881 |
| SUSTIVA 50MG | 50MG | CAPSULE | Discontinued | 2021-06-14 | 2023-04-01 | 140884 |
| SUSTIVA TABLETS | 600MG | TABLET | Discontinued | 2021-06-14 | 2022-10-01 | 140887 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256134 |
Showing 1 to 5 of 5